
Briggs Morrison who joined AstraZeneca in 2012 and played an instrumental part in defending its takeover by Pfizer, is abruptly …

The chairman of the NHS procurement and efficiency board Lord Carter has said the UK health body could save billions …

Turing Pharmaceuticals has appointed life sciences executive and medical researcher Dr Eliseo Salinas to the company as president of R&D. …

Draft guidance issued by NICE has seen rejections for products including Celgene’s Otelza and Astellas Pharma’s Xtandi, and a call …

British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …

Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …

A new, not-for-profit coalition has launched with a mission to tackle antimicrobial resistance (AMR) and what it sees as the …

Red Door Unlimited has appointed two consultants in Jock McEwan who joins as digital senior account director, and Gill Dunn …

The Myeloma UK Clinical Trial Network (CTN) has published data from its first trial marking a major milestone for the …

Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …

AstraZeneca is embarking upon a joint venture that will involve the building of a new $125 million small-molecule plant in …

Healthcare strategic marketing consultancy Cello Health Consulting has appointed Robert Stringer as a senior consultant. Stringer takes 20 years’ marketing experience …

The Department of Health and the ABPI have confirmed a payment of £207 million from pharma to underwrite growth of …

Diabetes specialist firm Novo Nordisk has launched a new treatment in the UK which combines two of the Danish firm’s …
The added value of wearable devices

Not a week goes by without a big pharma merger story, and now it’s the turn of Dublin-headquartered Shire that …

US science and tech development and commercialisation firm Allied Minds has appointed Kevin Sharer to its board of directors. Sharer …

One year can make all the difference. The 2014 American Society of Clinical Oncology (ASCO) meeting took place just weeks …

NICE has published draft guidance for two prostate cancer drugs, recommending a Bayer medicine but rejecting one from Ferring Pharmaceuticals. …

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …